Table 3.
Postoperative recurrence rates and hazard ratios in ARC-subCLSTs among sub-stages
Crude recurrence rate % [No.] | Hazard ratio [95% CI] | |
---|---|---|
Stage I | P = 0.002 | P < 0.001 |
CLST A1 [36] | 2.8 [1] | 1.00 [ref.] |
A2 [42] | 4.8 [2] | 1.84 [0.17- 20.26] |
B [23] | 17.4 [4] | 8.07 [0.90- 72.41] |
C1 [41] | 9.8 [4] | 3.90 [0.44- 34.92] |
C2 [25] | 28.0 [7] | 13.51 [1.66-109.98] |
D [20] | 35.0 [7] | 16.49 [2.03-134.14] |
Stage IA | P = 0.003 | P < 0.001 |
CLST A1 [32] | 3.1 [1] | 1.00 [ref.] |
A2 [33] | 3.0 [1] | 1.14 [0.07- 18.30] |
B [12] | 0.0 [0] | N.A. |
C1 [29] | 0.0 [0] | N.A. |
C2 [16] | 12.5 [2] | 5.14 [0.47- 56.86] |
D [8] | 37.5 [3] | 18.44 [1.88-181.10] |
Stage IB | P = 0.310 | P = 0.220 |
CLST A1 [4] | 0.0 [0] | 1.00 [ref.] |
A2 [9] | 11.1 [1] | N.A. |
B [11] | 36.4 [4] | N.A. |
C1 [12] | 33.3 [4] | N.A. |
C2 [9] | 55.6 [5] | N.A. |
D [12] | 33.3 [4] | N.A. |
ARC-subCLSTs, sub-clusters based on architectural elements; No., number of cases; CLST, cluster; P, P value for crude reccyrrence rate and harad ratio are calculated by Fisher's exact test and and Log-rank test, respectively; CI, confidence interval; ref., reference; N.A., not available;
*C3 (squamous cell carcinomas), excluded from anaysis.